LRP8 and neuroblastoma: The Trump research team identified LRP8, a low-density lipoprotein receptor, as a critical inhibitor of ferroptosis in MYCN-amplified neuroblastoma, with its regulatory mechanism potentially linked to selenocysteine metabolism.